A 54-year-old man in Delhi suffered injuries after he was allegedly thrashed by a young man on Thursday afternoon for ...

Cirrhosis progresses in stages, from a compensated phase with few symptoms to a decompensated phase with serious ...

The U.S. FDA granted breakthrough device designation to Mursla Bio Ltd.'s Evoliver. The biopsy blood test uses extracellular vesicles to survey hepatocellular carcinoma in high-risk cirrhotic patients ...

Background: It is currently recommended that all patients with liver cirrhosis undergo upper gastrointestinal endoscopy (UGIE) to identify those who have large esophageal varices (LEVx ...

In this study, we present a model based on the TGF-β and associated immune pathways for the HCC stratification in cirrhotic patients that incorporates biologically relevant proteins to capture ongoing ...

This project presents an interactive R Shiny dashboard built for analyzing and visualizing a real-world dataset on patients diagnosed with liver cirrhosis. The goal is to extract meaningful insights ...

This project presents an interactive R Shiny dashboard built for analyzing and visualizing a real-world dataset on patients diagnosed with liver cirrhosis. The goal is to extract meaningful insights ...

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to significantly improve cancer outcomes for at-risk ...

The pathophysiological mechanisms and the clinical conditions that drive cirrhotic patients to an ill-balanced metabolic state are multiple and they intertwine. Inadequate offer of nutrients ...

EvoLiver, a blood test that detects early-stage liver cancer with high accuracy, has gained breakthrough device designation from the FDA.

Multi-modal data integration of single-nuclei RNA and ATAC sequencing with spatial transcriptomics, provides new molecular insights into gene regulatory networks driving cell state transitions in ...